The COVID-19 RT-qPCR Test is a laboratory based test for the detection of ACTIVE infection caused by the SARS-COV-2 virus (otherwise known as Coronavirus COVID-19).
- Accurate & Reliable: FDA Authorized, >97% accuracy
- Simple & Convenient: At-home collection, Saliva-based test
- Seamless & Fast: Physician ordered, Results in 72 hours
How it Works:
Purchase your kit(s). Select your shipping and return preferences. When you are ready to send the test back, return to the website to register the kit and complete a medical questionnaire. Once your sample is received, results will be available within 72 hours.
We offer STAT processing (<24 hours) for an additional fee and courier pick up in NY, NJ, and CT. Reach out to firstname.lastname@example.org for information.
The Konsu Health kit will include instructions for collecting and returning the sample as well as return shipping materials.
The test is a real-time reverse transcription polymerase chain reaction (RT-qPCR) test. It was developed to detect the presence of two separate regions of the SARS-CoV-2 viral RNA, and analysis is performed in a high-complexity CLIA-certified laboratory. The test was validated under a rigorous IRB-approved protocol that included studies of symptomatic and asymptomatic patients, as well as samples from individuals presumed to not have COVID-19 as confirmed by third party laboratories. The following data was submitted to the FDA:
- Sensitivity: 97.1%
- Specificity: 98.2%
- Positive Predictive Value: 97.1%
- Negative Predictive Value: 98.2%
Unsure about how saliva tests compare to nasopharyngeal swabs? Read more here.
This home collection kit has not been FDA cleared or approved. This home collection kit has been authorized by the FDA under an EUA. This home collection kit has been authorized only for the home collection and maintenance of saliva specimens as an aid in detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens.
- Active COVID-19 virus detection
- Mailed to your home (return envelope included)
- Works with saliva (spit-based)
- Clinical Sensitivity 97.1%
- Specificity 98.2%
- FDA Authorized
- Insurance documentation provided